Risks of testosterone therapy in elderly men

Ranjith Ramasamy, James M. Dupree, Jason R. Kovac, Larry I. Lipshultz

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Testosterone supplementation therapy (TST) is a widely used treatment for men with late onset hypogonadism. The benefits seen with TST, such as improved libido and energy level, beneficial effects on bone density have been well documented. Although hypogonadism remains an independent risk factor for mortality, recent studies have examined the association between testosterone therapy and cardiovascular risk.

Original languageEnglish (US)
Article number11
StatePublished - Jan 15 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Risks of testosterone therapy in elderly men'. Together they form a unique fingerprint.

Cite this